Literature DB >> 12020607

Glutamate transporters in hyperammonemia.

Roger F Butterworth1.   

Abstract

Evidence suggests that increases in brain ammonia due to congenital urea cycle disorders, Reye Syndrome or liver failure have deleterious effects on the glutamate neurotransmitter system. In particular, ammonia exposure of the brain in vivo or in vitro preparations leads to alterations of glutamate transport. Exposure of cultured astrocytes to ammonia results in reduced high affinity uptake sites for glutamate due to a reduction in expression of the astrocytic glutamate transporter GLAST. On the other hand, acute liver failure leads to decreased expression of a second astrocytic glutamate transporter GLT-1 and a consequent reduction in glutamate transport sites in brain. Effects of the chronic exposure of brain to ammonia on cellular glutamate transport are less clear. The loss of glutamate transporter activity in brain in acute liver failure and hyperammonemia is associated with increased extracellular brain glutamate concentrations which may be responsible for the hyperexcitability and cerebral edema observed in hyperammonemic disorders.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12020607     DOI: 10.1016/s0197-0186(02)00027-x

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  9 in total

1.  Differential expression of the glutamate transporter GLT-1 in pancreas.

Authors:  James S Meabon; Aven Lee; Kole D Meeker; Lynn M Bekris; Robert K Fujimura; Chang-En Yu; G Stennis Watson; David V Pow; Ian R Sweet; David G Cook
Journal:  J Histochem Cytochem       Date:  2011-11-22       Impact factor: 2.479

2.  Pannexin1 as a novel cerebral target in pathogenesis of hepatic encephalopathy.

Authors:  Papia Mondal; Surendra Kumar Trigun
Journal:  Metab Brain Dis       Date:  2014-05-08       Impact factor: 3.584

Review 3.  Aspartate as an ergogenic supplement.

Authors:  François Trudeau
Journal:  Sports Med       Date:  2008       Impact factor: 11.136

4.  A(a)LS: Ammonia-induced amyotrophic lateral sclerosis.

Authors:  Bhavin Parekh
Journal:  F1000Res       Date:  2015-05-14

5.  Acute Liver Toxicity Modifies Protein Expression of Glutamate Transporters in Liver and Cerebellar Tissue.

Authors:  Catya Jiménez-Torres; Hoda El-Kehdy; Luisa C Hernández-Kelly; Etienne Sokal; Arturo Ortega; Mustapha Najimi
Journal:  Front Neurosci       Date:  2021-01-06       Impact factor: 4.677

6.  Thymoquinone improves cognitive and hippocampal long-term potentiation deficits due to hepatic encephalopathy in rats.

Authors:  Somayeh Hajipour; Yaghoob Farbood; Mahin Dianat; Mohammad Rashno; Laya Sadat Khorsandi; Alireza Sarkaki
Journal:  Iran J Basic Med Sci       Date:  2021-07       Impact factor: 2.699

Review 7.  Hepatic Encephalopathy: From Metabolic to Neurodegenerative.

Authors:  Rafael Ochoa-Sanchez; Farzaneh Tamnanloo; Christopher F Rose
Journal:  Neurochem Res       Date:  2021-06-15       Impact factor: 3.996

8.  Urea Cycle Disorders.

Authors:  Soledad Kleppe; Asad Mian; Brendan Lee
Journal:  Curr Treat Options Neurol       Date:  2003-07       Impact factor: 3.972

9.  Genetic networks of liver metabolism revealed by integration of metabolic and transcriptional profiling.

Authors:  Christine T Ferrara; Ping Wang; Elias Chaibub Neto; Robert D Stevens; James R Bain; Brett R Wenner; Olga R Ilkayeva; Mark P Keller; Daniel A Blasiole; Christina Kendziorski; Brian S Yandell; Christopher B Newgard; Alan D Attie
Journal:  PLoS Genet       Date:  2008-03-14       Impact factor: 5.917

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.